The Effects of Kinesio Taping in Women With Primary Dysmenorrhea

Sponsor
Ataturk Training and Research Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03915145
Collaborator
(none)
60
1
3
5.7
10.4

Study Details

Study Description

Brief Summary

The aim of our study was to investigate the effects of kinesio taping in women with primary dysmenorrhea.

Condition or Disease Intervention/Treatment Phase
  • Other: Kinesio tape application
  • Other: Sham Kinesio tape application
  • Other: No intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Assistant Professor, Physioterapist, PhD
Actual Study Start Date :
Mar 10, 2019
Anticipated Primary Completion Date :
Jun 1, 2019
Anticipated Study Completion Date :
Sep 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Kinesio tape group

Kinesio tape application has been applied

Other: Kinesio tape application
Kinesio tape application will be performed.Taping is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Sham Comparator: Sham group

Sham kinesio tape application has been applied

Other: Sham Kinesio tape application
Sham kinesio tape application will be performed. Sham taping is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Other: Control group

No intervention has been applied

Other: No intervention
The natural process will be followed from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Outcome Measures

Primary Outcome Measures

  1. The severity of menstrual pain assessed with Visual Analog Scale [An average of 2 weeks]

    A 10-cm Visual Analog Scale anchored from zero (no pain at all) to 10 (the worst pain I have ever felt) was used to determine the severity of each subject's menstrual pain.

Secondary Outcome Measures

  1. The complaints related to menstruation will be evaluated by a form prepared by the researchers [An average of 2 weeks]

    The form assessing the complaints related to menstruation will be evaluated existing complaints affect the patient and expressed as, no, little, mederate, very.

  2. The level of anxiety will be evaluated with The Spielberger State Trait Anxiety Inventory [An average of 2 weeks]

    The Spielberger State Trait Anxiety Inventory is a 40-item self-report inventory designed to measure both state anxiety section (current feelings of apprehension, worry, etc.) and trait anxiety section (continuous feelings of apprehension, worry, etc.). Each section is scored on four levels of anxiety intensity from 1="not at all" to 4="very much" and with a sum score between 20 and 80. A higher total score indicates more severe anxiety level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 to 35 years of age,

  • having Primary Dysmenorrhea

  • being volunteer women

Exclusion Criteria:
  • having give birth,

  • having a serious psychiatric disorder

  • having used oral contraceptive or depression drug in the last 6 month

  • having secondary dysmenorrhea

  • having irregular menstrual cycle

  • having allergy to taping

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara Yildirim Beyazit University Ankara Turkey

Sponsors and Collaborators

  • Ataturk Training and Research Hospital

Investigators

  • Principal Investigator: Seyda TOPRAK CELENAY, Ankara Yildirim Beyazıt University
  • Study Chair: Basak Kavalci, Gumushane University
  • Study Chair: Aysenur Karakus, Ankara Yildirim Beyazıt University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Seyda TOPRAK CELENAY, Assistant Professor, Ataturk Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT03915145
Other Study ID Numbers:
  • 442-15
First Posted:
Apr 16, 2019
Last Update Posted:
Apr 16, 2019
Last Verified:
Apr 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 16, 2019